Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer.

Kazuhiro SasoNorikatsu MiyoshiShiki FujinoMasaru SasakiMasayoshi YasuiMasayuki OhueTakayuki OginoHidekazu TakahashiMamoru UemuraChu MatsudaTsunekazu MizushimaYuichiro DokiHidetoshi Eguchi

Published in: Annals of surgical oncology (2020)

DPP9 was a poor prognostic factor for CRC and could be a new therapeutic target, while vildagliptin could be used as a repositioned drug for CRC treatment.

Keyphrases

poor prognosis
prognostic factors
long non coding rna
emergency department
adverse drug
drug induced